Wells Fargo & Company Kezar Life Sciences, Inc. Transaction History

Wells Fargo & Company

$410 Billion
Q1 2024

A detailed history of Wells Fargo & Company transactions in Kezar Life Sciences, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 89,700 shares of KZR stock, worth $60,996. This represents 0.0% of its overall portfolio holdings.

Number of Shares

89,700

Previous 95,815 6.38%

Holding current value

$60,996

Previous $91,000 12.09%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$0.8 - $1.05 $4,892 - $6,420	-6,115 Reduced 6.38%	89,700 $80,000
Q4 2023 Feb 09, 2024	SELL	$0.72 - $1.15 $14,880 - $23,768	-20,668 Reduced 17.74%	95,815 $91,000
Q3 2023 Nov 13, 2023	BUY	$1.08 - $2.54 $15,009 - $35,300	13,898 Added 13.55%	116,483 $138,000
Q2 2023 Aug 15, 2023	BUY	$2.31 - $3.06 $5,657 - $7,493	2,449 Added 2.45%	102,585 $251,000
Q1 2023 May 12, 2023	BUY	$3.13 - $7.31 $181,674 - $424,294	58,043 Added 137.89%	100,136 $313,000

Q4 2022 Feb 13, 2023	SELL	$6.39 - $8.8 $28,601 - $39,388	-4,476 Reduced 9.61%	42,093 $296,000
Q3 2022 Nov 14, 2022	SELL	$7.99 - $10.75 $320,726 - $431,515	-40,141 Reduced 46.29%	46,569 $400,000
Q2 2022 Aug 12, 2022	SELL	$4.58 - $17.13 $145,909 - $545,727	-31,858 Reduced 26.87%	86,710 $717,000
Q1 2022 May 16, 2022	SELL	$12.3 - $18.33 $375,801 - $560,036	-30,553 Reduced 20.49%	118,568 $1.97 Million
Q4 2021 Feb 14, 2022	SELL	$7.44 - $16.72 $770,709 - $1.73 Million	-103,590 Reduced 40.99%	149,121 $2.49 Million
Q3 2021 Nov 15, 2021	BUY	$4.85 - $9.73 $52,360 - $105,045	10,796 Added 4.46%	252,711 $2.18 Million
Q2 2021 Aug 16, 2021	SELL	$4.93 - $6.46 $72,199 - $94,606	-14,645 Reduced 5.71%	241,915 $1.31 Million
Q1 2021 May 13, 2021	SELL	$5.24 - $6.99 $302,096 - $402,987	-57,652 Reduced 18.35%	256,560 $1.53 Million
Q4 2020 Feb 09, 2021	BUY	$4.77 - $6.58 $408,951 - $564,129	85,734 Added 37.52%	314,212 $1.64 Million
Q3 2020 Nov 05, 2020	SELL	$4.36 - $5.5 $341,902 - $431,299	-78,418 Reduced 25.55%	228,478 $1.11 Million
Q2 2020 Aug 13, 2020	BUY	$3.6 - $7.75 $846,655 - $1.82 Million	235,182 Added 327.94%	306,896 $1.59 Million
Q1 2020 May 14, 2020	BUY	$2.77 - $5.75 $198,647 - $412,355	71,714 New	71,714 $312,000

Others Institutions Holding KZR

# of Institutions

Shares Held

44.7M

Call Options Held

2.6K

Put Options Held

600

View Full List

About Kezar Life Sciences, Inc.

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $46.5M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

More about KZR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Kezar Life Sciences, Inc. Transaction History